Amgen Inc (AMGN)

237.85
+2.40(+1.02%)
  • Volume:
    2,401
  • Bid/Ask:
    237.35/237.85
  • Day's Range:
    233.60 - 241.90
Unusual trading volume

Amgen has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

AMGN Overview

Prev. Close
235.45
Day's Range
233.6-241.9
Revenue
-
Open
235.4
52 wk Range
173.92-252
EPS
-
Volume
2,401
Market Cap
126.68B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,137
P/E Ratio
-
Beta
-
1-Year Change
29.16%
Shares Outstanding
534,930,850
Next Earnings Date
-
What is your sentiment on Amgen?
or
Vote to see community's results!

Amgen Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24300
  • Type:Equity
  • Market:Germany
  • ISIN:US0311621009
  • WKN:867900

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Analyst Price Target

Average249.81 (+8.23% Upside)
High295
Low182
Price230.82
No. of Analysts28
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyBuyStrong BuyBuy
Technical IndicatorsStrong SellStrong SellStrong BuyBuyStrong Buy
SummarySellNeutralStrong BuyStrong BuyStrong Buy